Design Therapeutics (DSGN) Interest Income - Net (2024 - 2026)

Design Therapeutics has reported Interest Income - Net for 3 years, with the latest figure at -$1.2 million in Q2 2026.

• Interest Income - Net for Q2 2026 came in at -$1.2 million, down 377.47% year-over-year; the trailing twelve-month figure through Jun 2026 was -$2.5 million (down 296.96% YoY), and the FY2025 annual result was -$53.7 billion, down 173.54% from the prior year.
• Interest Income - Net advanced to -$1.2 million in Q2 2026, from -$1.3 million in the prior quarter.
• Over five years, Interest Income - Net peaked at $1.1 million in Q1 2024 and troughed at -$1.3 million in Q1 2026.
• A 3-year average of $93300.0 and a median of $104000.0 in 2025 frame the typical range for Interest Income - Net.
• The widest annual swing landed in 2025, when Interest Income - Net sank 85.29%; it then sank 893.83% in 2026.
• A 3-year view of Interest Income - Net shows it stood at $406000.0 in 2024, then sank by 103.45% to -$14000.0 in 2025, then slumped by 8528.57% to -$1.2 million in 2026.
• Per Business Quant data, the three most recent Interest Income - Net figures were -$1.2 million in Q2 2026, -$1.3 million in Q1 2026, and -$14000.0 in Q4 2025.